Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02815371 · ClinicalTrials.gov registry record · NA
Laser Acupuncture Before and After Embryo Transfer Improves IVF Outcomes
A NA study, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 803
- Enrollment target
NCT02815371: Completed NA study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT02815371 is a NA study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 803 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02815371, a NA study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 803 participants
- Enrollment target
Study Summary
This study evaluated whether laser acupuncture at the time of embryo transfer (following in vitro fertilization) improves implantation rates. Patients were randomized to one of 4 groups at the time of embryo transfer: 1) laser acupuncture, 2) needle acupuncture, 3) sham laser acupuncture, 4) no treatment.
Primary Outcome
Number of gestational sacs seen on ultrasound per embryo transferred
Interventions
- PROCEDURE Needle Acupuncture
- PROCEDURE Laser Acupuncture
- PROCEDURE Sham Laser Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 803 participants |
| Start Date | 2005-06 |
| Est. Completion | 2008-01 |
| Phase | NA |
What the finished NCT02815371 record still lists
NCT02815371 is an interventional study that assigns participants to a tested intervention. The registered 803 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 3 interventions - of which Needle Acupuncture is the first listed.
NCT02815371 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02815371 about?
NCT02815371 is a clinical study titled "Laser Acupuncture Before and After Embryo Transfer Improves IVF Outcomes". This study evaluated whether laser acupuncture at the time of embryo transfer (following in vitro fertilization) improves implantation rates. Patients were randomized to one of 4 groups at the time of embryo transfer: 1) laser acupuncture, 2) needle acupuncture, 3) sham laser acupuncture, 4) no trea...
What is the current status of trial NCT02815371?
This trial is currently completed. It is a NA study. The enrollment target is 803 participants. The study started on 2005-06. Estimated completion is 2008-01.
What interventions are being tested in trial NCT02815371?
The interventions under investigation include: Needle Acupuncture (PROCEDURE), Laser Acupuncture (PROCEDURE), Sham Laser Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT02815371?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02815371's enrollment target sits among peer trials
803 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- NCT06522022 · 804 participants · NA
PTSD Screening in Pregnant Black Women
- NCT03524430 · 801 participants · NA
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia